| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on November 18, 2005
Accepted on January 24, 2006
Department of Pathology and Laboratory Medicine, Women and Infants Hospital and Brown Medical School, Providence, RI; and The Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
* To whom correspondence should be addressed. E-mail: gmesserl{at}wihri.org.
Context: Women experiencing depression have difficult psychosocial functioning and recent data suggest an earlier onset of menopause. Understanding the biological mechanism for the impairment of reproductive function associated with depression is important.
Objective: To determine if a lifetime history of depression is associated with reduced ovarian reserve as reflected in serum levels of the granulosa cell product, inhibin B.
Design: Residual serum samples from a subset of patients in the Harvard Study of Cycles and Moods.
Setting: Patients were recruited from seven Boston area communities.
Patients: Women with or without a history of major depression, based on structured clinical interviews for DSM-IV (SCID), were enrolled. A subset of patients who had provided an early follicular phase blood specimen at study enrollment and two or more other samples over the first 18-month period of follow-up were included.
Intervention: None.
Main Outcome Measure: Serum inhibin B levels.
Results: Serum FSH levels were higher in women with a history of depression, while inhibin B levels did not differ between groups. Body mass index and age were significantly and inversely related to serum inhibin B levels. Smoking history was noted, for the first time, to have a significant negative association with inhibin B levels.
Conclusions: Smoking has a direct negative effect on ovarian reserve, as suggested by decreased serum inhibin B levels. In contrast, effects of depression on the reproductive axis may occur at the level of the pituitary and/or hypothalamus rather than at the gonadal level, as suggested by increased serum FSH levels.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |